Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/20/2008WO2008057171A3 4-1 bb ligand in inflammatory diseases
11/20/2008WO2008048976A3 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors
11/20/2008WO2008043033A3 Fibrillation-resistant insulin and insulin analogues
11/20/2008WO2008042479A3 Methods and compositions related to bacterial flagellum and nanotube formation
11/20/2008WO2008036127A3 Oligonucleotide analogs having cationic intersubunit linkages
11/20/2008WO2008030613A3 Hybrid suppressor trna for vertebrate cells
11/20/2008WO2008013985A3 Use of heat shock activators for tissue regeneration
11/20/2008WO2008008766A3 Co-expression of proline hydroxylases to facilitate hyp-glycosylation of proteins expressed and secreted in plant cells
11/20/2008WO2008005562A3 Rna silencing compositions and methods for the treatment of huntington's disease
11/20/2008WO2008005281A3 Genes associated with chemotherapy response and uses thereof
11/20/2008WO2007149870A3 Two-color fluorescent reporter for alternative pre-mrna splicing
11/20/2008WO2007123876A3 Transgenic plants comprising a mutant phytochrome and showing altered photomorphogenesis
11/20/2008WO2007120541A3 Method for cloning and expression of nrui restriction endonuclease
11/20/2008WO2007089873B1 Fermentation process for continuous plasmid dna production
11/20/2008WO2007076166A3 Methods of making modular fusion protein expression products
11/20/2008WO2006121569A3 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/20/2008WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
11/20/2008US20080289067 Polypeptides having endoglucanase activity and polynucleotides encoding same
11/20/2008US20080289066 Self-Processing Plants and Plant Parts
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080289064 Cotton Cultivar DP 141 B2RF
11/20/2008US20080289063 Plastid Transformation of Maize
11/20/2008US20080289062 Sorghum aluminum tolerance gene, SbMATE
11/20/2008US20080289061 Identification of seeds or plants using phenotypic markers
11/20/2008US20080289060 Herbicide tolerant rice plants and methods for identifying same
11/20/2008US20080289059 Methods for developing animal models
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080288264 Methods for generation or increasing revenues from crops
11/20/2008US20080287665 CANINE IgG NUCLEIC ACID MOLECULES
11/20/2008US20080287664 Hsp60 from arthrobacter
11/20/2008US20080287651 Silk Thread Containing Spider Thread Protein and Silk Worm Producing the Silk Thread
11/20/2008US20080287483 Polyketides and Their Synthesis and Use
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287388 Human G-Protein Coupled Receptor
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287384 Methods of Identifying Agents Having Antiangiogenic Activity
11/20/2008US20080287383 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
11/20/2008US20080287380 Antisense Oligonucleotides Against Cpla2, Compositions and Uses Thereof
11/20/2008US20080287379 Oligonucleotide Complex Compositions and Methods of Use as Gene Alteration Tools
11/20/2008US20080287364 Bitter Taste Receptors
11/20/2008US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/20/2008US20080287362 Compositions and Methods for the Detection of Trypanosoma Cruzi Infection
11/20/2008US20080287361 Compositions and methods of using CRMP-1 and its fragments for treating cancer
11/20/2008US20080287358 Regulatory T Cell Mediator Proteins and Uses Thereof
11/20/2008US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer
11/20/2008US20080287356 Chimeric Proteins, Their Preparation and Pharmaceutical Compositions Containing Them
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287349 Fibroblast growth factor 20 and methods of use thereof
11/20/2008US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
11/20/2008US20080287321 cDNA synthesis improvements
11/20/2008US20080287317 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays
11/20/2008US20080287314 Methods for modulating cellular and organismal phenotypes
11/20/2008US20080287311 Membrane-Translocating Peptides
11/20/2008US20080287310 Human Sweet and Umami Taste Receptor Variants
11/20/2008US20080287309 Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby
11/20/2008US20080287304 Mixture of at Least Two Fusion Proteins as Well as Their Production and Use
11/20/2008US20080286871 Modular genomes for synthetic biology and metabolic engineering
11/20/2008US20080286870 Xylitol synthesis mutant of xylose-utilizing zymomonas for ethanol production
11/20/2008US20080286869 Capable of expressing a nucleotide of interest which encodes an RNA or protein which is harmful to a cell; lentiviral packaging cell stably produces lentiviral Gag-Pol continuously for at least 3 months
11/20/2008US20080286866 Nucleic acid compounds for inhibiting vegf gene expression and uses thereof
11/20/2008US20080286861 Compositions and Methods for the Treatment of Immune Related Diseases
11/20/2008US20080286860 Cancer specific promoters
11/20/2008US20080286848 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
11/20/2008US20080286844 Metabolically Engineered Cells for the Production of Resveratrol or an Oligomeric or Glycosidically-Bound Derivative Thereof
11/20/2008US20080286841 Pgro expression units
11/20/2008US20080286836 Retroviral gene transfer element for enhancement of heterologous gene sequences in cells
11/20/2008US20080286834 Leader Sequences For Directing Secretion of Polypeptides and Methods For Production Thereof
11/20/2008US20080286833 Expression vector, a transformant carrying the same and a method for producing heterologous protein
11/20/2008US20080286828 Materials and methods relating to g-protein coupled receptor oligomers
11/20/2008US20080286824 System for Screening Cells for High Expression of a Protein of Interest (Poi)
11/20/2008US20080286821 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2008US20080286817 Novel allergens and treatment
11/20/2008US20080286814 Biomarkers for Detecting Cancer
11/20/2008US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof
11/20/2008US20080286809 Methods
11/20/2008US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof
11/20/2008US20080286805 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286795 Method of nucleic acid amplification
11/20/2008US20080286789 Genomic polymorphism for predicting therapeutic response
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286779 Host Cells Containing Multiple Integrating Vectors
11/20/2008US20080286770 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus
11/20/2008US20080286762 enables detection and analysis of genes with high degree of sensitivity and high degree of accuracy, and reduction of the size and cost of a gene polymorphism analyzing system
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286752 Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV
11/20/2008US20080286749 Enhanced protein expression using auto-induction media
11/20/2008US20080286436 Delta-5 desaturase and its use in making polyunsaturated fatty acids
11/20/2008US20080286415 Proteases
11/20/2008US20080286412 Lactase with very low arylsulfatase activity; making dairy, food products such as yogurt or lactose-free milk with no off-taste even after long storage
11/20/2008US20080286381 biodrug comprising a nucleic acid sequence of nucleic acid; anticarcinogenic agents or antitumor agents; including cisplatin and carboplatin; effective chemotherapeutic agents in efficiency, being less invasive or toxic, and increased rate of recovery
11/20/2008US20080286361 deliverying a therapeutic agent (DNA, CFTR genes, peptide, antibody etc. ) contained in targeting particles (e.g. magnetite) to a cell using an electromagnet to apply a magnetic force so as to tend to move particles towards magnet and at the same time moving the magnet
11/20/2008US20080286353 Cationic liposomes containing immune response generating moieties
11/20/2008US20080286323 Human Therapeutic Cells Secreting Nerve Growth Factor
11/20/2008US20080286312 Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes
11/20/2008US20080286310 Sequences coding Shiga toxin are deleted and those encoding bacterial adhesin protein intimin, the locus of enterocyte effacement encoded regulator, and the translocated intimin receptor are mutated to inactivate them
11/20/2008US20080286309 Portion of SpaA protein is deleted for protection from Erysipelothrix rhusiopathiae infection; genetic engineering; Porcine erysipelas; high purity
1 ... 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 ... 4023